A fine pharmaceutical Limited by Share Ltd, founded in October 2007, is located in Xingtai City, Hebei province Caozhuang Management District, covers an area of 200 mu, the registered capital of 103 million 800 thousand yuan, the existing staff of nearly 500 people, in recent years through the high-tech enterprises, the state and local joint engineering laboratory, provincial enterprise technology center and a series of certification, was named "Hebei province technology innovation demonstration enterprise", "Hebei province science and technology small and medium-sized enterprise"; and the provincial government approved the establishment of the academician workstation in the company. December 2015 in the new three board listing, securities code 835033, in June 2016, while in line with the profitability and growth of the first set of standards into the innovation level of two. The company is engaged in R & D, sterile APIs and amino acid and peptide derivatives of the professional production and sales. The company's technology team in cooperation with the United States CODX company, biological enzyme Tianjin University, Jiangnan University, after ten years of research, patent 36, aseptic crystallization technology, microbial fermentation amino acid production technology, biological enzyme technology etc. its independent development to break the blockade of foreign manufacturers for many years, to fill the domestic blank, technology the level reached the international advanced level. The main products of the company are sterile arginine, anhydrous sodium carbonate, and sterile sodium glutamine. The domestic market share is close to 100%. Recently, the world famous scientist, Nobel prize winner, entitled "the father of Dr. Ferid Murad nitric oxide" hired as chief scientific adviser, and signed a strategic cooperation agreement, to lay the foundation for building cutting-edge medicine industry base and biomedical technology transformation, marking the company into a world-class leading enterprise entered a new milepost of amino acid. The future, the company will rely on the core technology accumulated over the years, team cohesion wisdom, gather all resources, continuous innovation, to create a fine pharmaceutical industry to become the world's most influential and most professional manufacturer of series products of amino acids and peptides.
CN
